Overview of clinical research design.

@article{Hartung2009OverviewOC,
  title={Overview of clinical research design.},
  author={Daniel M. Hartung and Daniel R. Touchette},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2009},
  volume={66 4},
  pages={
          398-408
        }
}
  • D. Hartung, D. Touchette
  • Published 15 February 2009
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
PURPOSE Basic concepts and terminology of clinical research design are presented for new clinical investigators. SUMMARY Clinical research, research involving human subjects, can be described as either observational or experimental. The findings of all clinical research can be threatened by issues of bias and confounding. Biases are systematic errors in how study subjects are selected or measured, which result in false inferences. Confounding is a distortion in findings that is attributable… 
An introduction to the fundamentals of cohort and case-control studies.
  • J. Gamble
  • Medicine
    The Canadian journal of hospital pharmacy
  • 2014
TLDR
This article reviews for the practising pharmacist the fundamental design elements and foundational methodologic knowledge for conducting cohort and case–control studies, 2 common and robust observational study designs for elucidating drug–outcome associations.
A practical guide to conducting and writing medical record review studies.
  • A. Patanwala
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2017
TLDR
The quality of medical record review studies and the likelihood of their acceptance for publication can be improved through adherence to recommended standards of research design, data collection and analysis, ethical authorship, and manuscript preparation.
Application of a Single-Case Research Design to Present the Effectiveness of Rehabilitation in the Clinic
Clinical benefits of rehabilitation are very difficult to present because of various factors such as very small sample sizes, no control comparison, or short period of intervention. However, clinical
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
TLDR
The NordiNet® IOS and ANSWER Program® studies will provide valid insights into the effectiveness and safety of GH treatment across a diverse and large patient population treated in accordance with real-world clinical practice and following the Good Pharmacoepidemiological Practice and STrengthening the Reporting of OBservational studies in Epidemiology guidelines.
Dietary inflammatory index and risk of gynecological cancers: a systematic review and meta-analysis of observational studies
TLDR
This meta-analysis suggests that elevated DII is independently associated with a higher risk of gynecological cancers, especially patients with ovarian cancer and endometrial cancer and among obese participants.
Letter to the Editor Regarding the Article “Asian ethnicity: a risk factor for adhesive capsulitis?”
TLDR
The study concludes that Asian ethnicity is an independent risk factor with an adjusted odds ratio (OR) of 3.6, and the inference of the authors regarding the OR for Asian ethnicity and the development of adhesive capsulitism may be an overvalued measure.
Part II: Statistics in practice: Statistics overview
Target audience for this application-based activity: Pharmacotherapy specialists and advancedlevel clinical pharmacists using statistics for research, assessment of validity, interpretation of risk,
Research Methods in Enhanced Recovery After Surgery
TLDR
Research in enhanced recovery after surgery (ERAS) covers a broad range of topics from basic science to population-level studies and aims to promote high standards of care with data that are relevant to practice, reproducible, and generalizable to the field.
Dietary Supplements: Understanding the Complexity of Use and Applications to Health
  • E. Secor
  • Medicine, Political Science
  • 2020
TLDR
This chapter will provide an overview of dietary supplements with a focus on issues relating to nomenclature, understanding of the nutraceutical marketplace, and key regulatory issues, and a deeper dive into how best to assess reputable manufacturers as well as supplement formulations.
Correlational Study of Sleep Apnea Patient Characteristics With Discharge Locations.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 38 REFERENCES
An overview of clinical research: the lay of the land
Evaluating medication effects outside of clinical trials: new-user designs.
  • W. Ray
  • Medicine
    American journal of epidemiology
  • 2003
TLDR
This article provides several examples of medications for which the hazard function varies with time and thus would be subject to prevalent user bias and argues that new-user designs should be used more frequently in pharmacoepidemiology.
Case-control studies: research in reverse
Bias and causal associations in observational research
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.
TLDR
Increasing the supply of pragmatic or practical clinical trials will depend on the development of a mechanism to establish priorities for these studies, significant expansion of an infrastructure to conduct clinical research within the health care delivery system, more reliance on high-quality evidence by health care decision makers, and a substantial increase in public and private funding forThese studies.
Bias in analytic research.
  • D. Sackett
  • Medicine
    Journal of chronic diseases
  • 1979
Case–crossover and case–time–control designs as alternatives in pharmacoepidemiologic research
Standard cohort and case–control designs are suited to the study of cumulative effects of chronic exposures, but they are prone to confounding by indication. Case–crossover and case–time–control
Trials to assess equivalence: the importance of rigorous methods
The aim of an equivalence trial is to show the therapeutic equivalence of two treatments, usually a new drug under development and an existing drug for the same disease used as a standard active
Cohort studies: marching towards outcomes
Fundamentals of Clinical Trials
Introduction to Clinical Trials * What Is The Question? * Study Population * Basic Study Design * The Randomization Process * Blindness * Sample Size * Baseline Assessment * Recruitment of Study
...
1
2
3
4
...